CIK 0001469443 · Non-accelerated filer<br>Smaller reporting company
Arcadia Biosciences, Inc.
Sign in to watch- Ticker
- RKDA
- Exchange
- Nasdaq
- Industry
- Beverages
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810571538
- Phone
- 214-974-8921
- Business address
- 5956 SHERRY LANE, SUITE 2000, DALLAS, TX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-03 | Haley Pamela Chief Financial Officer | Purchase | +700 | $3.16 | $2K | 2,638 |
| 2020-07-08 | Comcowich Kevin Director | Grant or award · Stock Option (right to buy) | +5,273 | 55,610 | ||
| 2020-07-08 | Murray Lilian Shackelford Director | Grant or award · Stock Option (right to buy) | +753 | 23,210 | ||
| 2020-06-01 | Yoder Amy Director | Grant or award · Stock Option (right to buy) | +9,137 | 29,376 | ||
| 2020-06-01 | Murray Lilian Shackelford Director | Grant or award · Stock Option (right to buy) | +9,137 | 22,457 | ||
| 2020-06-01 | Comcowich Kevin Director | Grant or award · Stock Option (right to buy) | +21,320 | 50,338 | ||
| 2020-06-01 | Bolles Albert D. Director | Grant or award · Stock Option (right to buy) | +9,137 | 27,463 | ||
| 2020-06-01 | WALLER GREGORY D Director | Grant or award · Stock Option (right to buy) | +9,137 | 25,222 | ||
| 2020-04-01 | Shultz Randall Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +18,000 | 60,000 | ||
| 2020-02-03 | Haley Pamela Chief Financial Officer | Purchase | +700 | $1.72 | $1K | 1,938 |
| 2020-02-03 | Haley Pamela Chief Financial Officer | Grant or award · Stock Option (right to buy) | +40,000 | 58,588 | ||
| 2020-02-03 | Reiter Sarah Chief Commercial Officer | Purchase | +700 | $1.72 | $1K | 3,800 |
| 2020-02-03 | Reiter Sarah Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 121,705 | ||
| 2020-02-03 | Plavan Matthew T Chief Executive Officer | Purchase | +700 | $1.72 | $1K | 13,700 |
| 2020-02-03 | Plavan Matthew T Chief Executive Officer | Grant or award · Stock Option (right to buy) | +76,000 | 185,450 | ||
| 2019-12-23 | Reiter Sarah Chief Commercial Officer | Purchase | +900 | $5.95 | $5K | 3,100 |
| 2019-11-19 | Reiter Sarah Chief Commercial Officer | Purchase | +1,000 | $4.52 | $5K | 2,200 |
| 2019-11-18 | Murray Lilian Shackelford Director | Purchase | +5,000 | $4.25 | $21K | 8,524 |
| 2019-11-14 | Plavan Matthew T Chief Executive Officer | Purchase | +1,000 | $4.08 | $4K | 13,000 |
| 2019-09-23 | Plavan Matthew T Chief Executive Officer | Purchase | +2,000 | $5.25 | $11K | 12,000 |
Page 4 of 7 · 126 trades